Fundraising FoxInnovative Cardiovascular Solutions
Kalamazoo, US · Founded 2012 · Michigan LLC
Find your way into Innovative Cardiovascular Solutions
Sign up to see every warm intro you have to Innovative Cardiovascular Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Innovative Cardiovascular Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RK
Robert Kevin PlemmonsManager
SP
Shayne PlemmonsManager
WM
William MerhiManager
Funding
SEC filings, press & company announcements$12.6M disclosed across 6 of 8 rounds · 2014–2021
- $5MSeries BJul 2017 · 3 sourcesSource ↗
▶$654.6KraisedJan 2022 · 10 investors · BiotechnologyRule 506(b)
▶$654.6KraisedJan 2022 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William MerhiExecutive Officer, Director
- Shayne PlemmonsExecutive Officer, Director
- Robert PlemmonsExecutive Officer, Director
- Offering amount
- $5.3M
- Amount sold
- $654.6K
- First sale
- Dec 2021
- Incorporated
- Limited Liability Company, Michigan
- Federal exemptions
- 06b
▶$269.6KraisedOct 2020 · 8 investors · BiotechnologyRule 506(b)
▶$269.6KraisedOct 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shayne PlemmonsExecutive Officer, Director
- Robert PlemmonsExecutive Officer, Director
- William MerhiExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $269.6K
- First sale
- Oct 2020
- Incorporated
- Limited Liability Company, Michigan
- Federal exemptions
- 06b
▶$519.3KraisedSep 2018 · 16 investors · BiotechnologyRule 506(b)
▶$519.3KraisedSep 2018 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William MerhiExecutive Officer, Director
- Shayne PlemmonsExecutive Officer, Director
- Robert PlemmonsExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $519.3K
- Minimum investment
- $10K
- First sale
- Aug 2018
- Incorporated
- Limited Liability Company, Michigan
- Federal exemptions
- 06b
▶$3.1MraisedApr 2017 · 97 investors · BiotechnologyRule 506(b)
▶$3.1MraisedApr 2017 · 97 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert Kevin PlemmonsExecutive Officer, Director
- Shayne PlemmonsExecutive Officer, Director
- William MerhiExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $3.1M
- Minimum investment
- $25K
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Michigan, 2012
- Federal exemptions
- 06b
▶$3.1MraisedSep 2014 · 56 investors · BiotechnologyRule 506(b)
▶$3.1MraisedSep 2014 · 56 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William MerhiExecutive Officer, Director
- Robert Kevin PlemmonsExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.1M
- Minimum investment
- $25K
- First sale
- Mar 2014
- Incorporated
- Limited Liability Company, Michigan, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Innovative Cardiovascular Solutions raised?
- Innovative Cardiovascular Solutions has disclosed $12.6M raised across 6 of its 8 known rounds.
- Where is Innovative Cardiovascular Solutions headquartered?
- Innovative Cardiovascular Solutions is headquartered in Kalamazoo, US.